Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2024
5 years of board service in total across 2 boards, counting each seat separately. Longest: Arrowhead Pharmaceuticals Inc., 2 years.
Arrowhead Pharmaceuticals Inc.
Director
Zenas BioPharma Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 18, 2024 | Arrowhead Pharmaceuticals Inc. | Grant or award | +16,733 | $22.99 | $384,692 |
| Sep 25, 2024 | Arrowhead Pharmaceuticals Inc. | Gift | −5,650 | — | — |
| Sep 13, 2024 | Zenas BioPharma Inc. | Open-market purchase | +58,823 | $17.00 | $999,991 |
| Apr 18, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market purchase | +500 | $22.00 | $11,000 |
| Apr 10, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market purchase | +500 | $25.00 | $12,500 |
| Apr 2, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market purchase | +150 | $27.34 | $4,101 |
| Mar 26, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market purchase | +850 | $27.50 | $23,375 |
| Mar 22, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market purchase | +400 | $28.00 | $11,200 |
| Mar 20, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market purchase | +1,000 | $27.50 | $27,500 |
| Mar 19, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market purchase | +1,000 | $28.00 | $28,000 |
| Mar 18, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market purchase | +1,000 | $27.49 | $27,490 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.